A Double-blind, randomized, placebo-controlled study to assess the safety, antiviral activity and pharmacokinetics of GSK2336805 when given as monotherapy and in combination with peginterferon alfa-2a and ribavirin in hepatitis C virus genotype 1-infected

✍ Scribed by Gardner, Stephen; Cutrell, Amy; Elko-Simms, Cindy; Adkison, Kimberly; Hamatake, Robert; Walker, Jill; Rodriguez-Torres, Maribel; Hong, Zhi

• Book ID: 127113866
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 221 KB
• Volume: 34
• Category: Article
• ISSN: 0106-9543
• DOI: 10.1111/liv.12334